Statistics for Harmony Biosciences Holdings, (id:6434 HRMY)

Valuation metrics

Market cap

1.89B

Enterprise value

1.67B

Trailing P/E (ttm)

15.67

Forward P/E

10.14

PEG ratio

10.14

Price/Sales (ttm)

2.77

Price/Book (mrq)

3.16

Enterprise Value/Revenue

2.45

Enterprise Value/EBITDA

8.36

Overview

Shares outstanding

57.03M

Float

44.06M

Shares short

6.06M

% Held by insiders

0.12%

% Held by institutions

0.93%

Average volume (10 days)

611.34K

Average volume (90 days)

Price summary

52-Week low

28.14

52-Week high

41.61

52-Week change

14.79%

Beta

0.77

50-Day moving average

35.98

200-Day moving average

32.94

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

17.98%

Operating margin

33.17%

Operational effectiveness

Return on assets

12.84%

Return on equity

22.75%

Income statement

Revenue (ttm)

11.92

Revenue per share (ttm)

11.92

Quarterly revenue growth (yoy)

0.20

Gross profit (ttm)

460.79M

EBITDA

228.32M

Net income to common (ttm)

122.62M

Diluted EPS (ttm)

2.11

Quarterly earnings growth (yoy)

19.80%

Balance sheet

Total cash (mrq)

410.48M

Total cash per share (mrq)

7.20

Total debt (mrq)

185.24M

Total Debt/Equity (mrq)

31.04

Current ratio (mrq)

323.90%

Book value per share (mrq)

10.46

Cash flow

Cash flow statement

220.92M

Levered free cash flow (LFCF)

168.65M